Darvon Heart Attack Lawyer in New York City

Xanodyne Concealed the Truth About Darvon Heart Risks

The painkiller drugs Darvon and Darvocet have been recalled and pulled off the market under pressure from public health officials, indicating that Darvon and Darvocet cause irregular heart rhythms that are dangerous.

The drugs were first approved in the 1950s as opioids indicated for treatment of moderate pain. The announcement of the recall of Darvon and Darvocet, which has been a popular prescription drug since the 1970s, was made by the Food and Drug Administration (“F.D.A.”) on November 19, 2010.

The impetus for the FDA’s request was data that verified fears that the active ingredient, propoxyphene, creates fatal cardiac rhythms.

This is not a surprising recall, at least as far as the manufacturer should be concerned. In fact, Dr. Sidley Wolfe of the Public Citizen’s Health Research Group stated that it was a situation of “too little, too late;” and, pointed to the fact that the drugs were prohibited in the United Kingdom more than five (5) years ago.

Darvon Manufacturer Failed to Disclose Heart Risks

There are two essential components of any drug: First, it must be efficacious, that is, effective to respond to the illness it is intended to treat. Second, it must be safe. Applying the two essential ingredients to Darvon, while it might have been a useful drug to palliate, it posed too many risks (i.e. heart attacks) to qualify as a safe drug.

Indeed, if, the manufacturer had disclosed to the F.D.A. that its own clinical trials were not sufficiently broad to test the impact of Darvon, the likelihood is that the F.D.A. would not have approved the drug.

Legal Help for Darvon Users

If you, a family member, or a friend have used Darvon and have had a heart attack, please contact Finz & Finz, P.C., now at (855) TOP-FIRM to speak with an experienced New York City defective drug litigation lawyer or simply fill out the Free Darvon Case Evaluation form.